Abstract
Previous chapters in this book (Chaps. 3 and 5–13) describe hereditary cancer syndromes that confer a substantial increase in risk for developing a particular malignancy. Such syndromes are considered to be Mendelian diseases, as the pattern of affected patients within an extended family closely follows the pattern of transmission of genes in a diploid organism as understood by Mendel’s laws of inheritance. DNA variants – or mutations – that underlie Mendelian diseases or traits are highly penetrant. That is, by inheriting the disease mutation or allele, an individual has a very high chance of developing the disease in question.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reich DE, Cargill M, Bolk S et al (2001) Linkage disequilibrium in the human genome. Nature 411:199–204
Guttmacher AE, Collins FS (2002) Genomic medicine – a primer. N Engl J Med 347:1512–1520
Foulkes WD (2008) Inherited susceptibility to common cancers. N Engl J Med 359:2143–2153
Houlston RS, Peto J (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene 23:6471–6476
Hunter DJ, Altshuler D, Rader DJ (2008) From Darwin’s finches to canaries in the coal mine – mining the genome for new biology. N Engl J Med 358:2760–2763
Ponder BA (2001) Cancer genetics. Nature 411:336–341
Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40:17–22
(2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 83:1301–1308
Reich DE, Lander ES (2001) On the allelic spectrum of human disease. Trends Genet 17:502–510
Dib C, Faure S, Fizames C et al (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152–154
Li WH, Sadler LA (1991) Low nucleotide diversity in man. Genetics 129:513–523
Sachidanandam R, Weissman D, Schmidt SC et al (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928–933
Entrez SNP, http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp.
The International HapMap Consortium (2003) The International HapMap Project. Nature 426:789–796
International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299–1320
Hinds DA, Stuve LL, Nilsen GB et al (2005) Whole-genome patterns of common DNA variation in three human populations. Science 307:1072–1079
Frazer KA, Ballinger DG, Cox DR et al (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851–861
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
Hunter DJ, Riboli E, Haiman CA et al (2005) A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 5:977–985
Chen YC, Kraft P, Bretsky P et al (2007) Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 16:1973–1981
Feigelson HS, Cox DG, Cann HM et al (2006) Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 66:2468–2475
Kraft P, Pharoah P, Chanock SJ et al (2005) Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet 1:e68
Freedman ML, Penney KL, Stram DO et al (2005) A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res 65:7516–7522
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182
Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45–61
Freedman ML, Reich D, Penney KL et al (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36:388–393
Campbell CD, Ogburn EL, Lunetta KL et al (2005) Demonstrating stratification in a European American population. Nat Genet 37:868–872
Altshuler D, Daly MJ, Lander ES (2008) Genetic mapping in human disease. Science 322:881–888
Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093
Thomas G, Jacobs KB, Yeager M et al (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40:310–315
Houlston RS, Webb E, Broderick P et al (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 40:1426–1435
Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359:1367–1380
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Choy, E., Altshuler, D. (2010). The HapMap Project and Low-Penetrance Cancer Susceptibility Alleles. In: Chung, D., Haber, D. (eds) Principles of Clinical Cancer Genetics. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-93846-2_14
Download citation
DOI: https://doi.org/10.1007/978-0-387-93846-2_14
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-93844-8
Online ISBN: 978-0-387-93846-2
eBook Packages: MedicineMedicine (R0)